A higher [18F]FDG uptake in the primary BC was shown to correlate with more aggressive histopathological markers (e.g., higher tumor grade, negativity for estrogen receptors (ER) and TN status) [12, 13] and poorer survival [14]. The gene discussed is ESR1; the disease is breast cancer.